Elizabeth Lightbody, Associate Director of Clinical Development at Adela, shared a post on LinkedIn:
“Another year, another ASCO! Looking forward to a great few days of exciting research updates, insightful discussions, and connecting with leaders across oncology.
If you’re attending, stop by Poster 541 tomorrow between 1:30-4:30 PM to see Adela’s updated classifier data for recurrence detection in head and neck cancer, building on our previously reported clinical validation results published in Annals of Oncology. See you there!”
Other articles about Head and Neck Cancer on OncoDaily.